{"id":"W2525261975","doi":"10.1200/jco.2015.33.3_suppl.276","title":"Baseline demographics of the randomized, placebo-controlled, double-blind, phase III RADIANT-4 study of everolimus in nonfunctional gastrointestinal (GI) or lung neuroendocrine tumors (NET).","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Everolimus; Medicine; Clinical endpoint; Neuroendocrine tumors; Internal medicine; Placebo; Concomitant; Randomized controlled trial; Gastroenterology; Progression-free survival; Oncology; Surgery; Pathology; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.01038214,0.0003338923,0.004983888,0.0007587363,0.00004725502,0.00001023328,0.0005941068,0.00003673793,0.0001363761],"category_scores_gemma":[0.04161728,0.0001814572,0.001106826,0.0008653568,0.0009349136,0.0002113581,0.0002116472,0.002505133,0.000002193538],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001338506,"about_ca_system_score_gemma":0.004523524,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001319042,"about_ca_topic_score_gemma":0.0006161334,"domain_scores_codex":[0.9866832,0.00397323,0.006711291,0.0003764624,0.001680524,0.000575285],"domain_scores_gemma":[0.9778455,0.01457453,0.004536463,0.0004741435,0.001734769,0.0008346263],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8972102,0.01309666,0.07416055,0.00005888399,0.0004350733,0.01071583,0.00004927438,0.00113777,0.00007477753,0.00003168928,0.001753508,0.001275815],"study_design_scores_gemma":[0.9302338,0.04392066,0.003244067,0.0002531826,0.0008404264,0.01605454,0.0006916618,0.003902632,0.00005558785,0.0000831256,0.0006088369,0.0001114773],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9904144,0.0003148328,0.0002083057,0.004213512,0.0009371037,0.003455998,0.000007645173,0.00001008005,0.000438106],"genre_scores_gemma":[0.9970684,0.0002073597,0.0009959198,0.0004838368,0.0008110804,0.00006363437,0.000002270782,0.00003573803,0.0003317331],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07091647,"threshold_uncertainty_score":0.9997962,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.143919802945755,"score_gpt":0.4773111673000061,"score_spread":0.3333913643542512,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}